- €14.19bn
- €19.11bn
- €3.54bn
Sartorius rises after Berenberg upgrade
Sartorius down premarket after margin disappoints
Germany's Sartorius Q1 revenue rises 7.5% in constant currencies
Brief: Sartorius Q1 Adjusted EBITDA Margin 29.7%
GS upgrades Sartorius Stedim to 'buy' after share price pullback
Brief: Sartorius Shareholders Approve Dividend Of EUR 0.74 Per Preference Share, EUR 0.73 Per Ordinary Share
Sartorius, Stedim Biotech shares rise on 'positive' mid-term guidance
Brief: Sartorius AG - Mid-Term Outlook: Sales Growth At 8 To 11 Percent Per Year
Brief: Sartorius Sharpens Strategy With Biopharma Focus, Sets New Midterm Growth Targets
Brief: Sartorius Proposes Dividend Of 0.74 Euros Per Preference Share
Europe Research Roundup: Berkeley Group, Next 15 Group, Westwing Group
Sartorius rises after full year results
Germany's Sartorius 2025 revenue just shy of analyst expectations
Brief: Sartorius Forecasts 2026 Sales Revenue Growth In Constant Currencies To Be Between Around 5 And 9 Percent
RBC cuts Sartorius on limited near-term upside potential
Top of the Street: Continental, Holcim, Heidelberg Materials
BNP picks medtech favourites, sees re-rating in H2 2026
Europe Research Roundup: Auto1 Group, Roche Holding, Sanofi
Europe Research Roundup: Aryzta, Secunet Security Networks, Whitbread